A study of serum C peptide levels in newly detected diabetic patients in tertiary care hospital


  • Balakrishna Teli Department of Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India
  • Prabhu S. Department of Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India
  • Sneha Biradar Department of Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India




Diabetes mellitus, C-peptide, BMI


Background: Diabetes mellitus (DM) refers to a group of common metabolic disorders that share the phenotype of hyperglycemia. The deficiency of C-peptide in type 1 DM or its excess in type 2 DM leads to the development of disorders which includes the cardiovascular, nervous, excretory and other systems. The present study is done to assess the serum C-peptide levels in newly detected diabetic patients and its significance in classification of diabetes and deciding about management.

Methods: This cross sectional study was conducted within the hospitals attached to Bangalore medical college and research institute. 65 newly detected diabetes patients who gave consent for study and satisfy the inclusion criteria were included in the study. Data was collected using semi structured questionnaire, clinical examination and relevant investigations. Statistical analysis was performed using SPSS software. A p value of <0.05 was considered significant.

Results: C-peptide levels showed that 34 (52.3%) subjects had C-peptide levels >2 followed by 10 (15.4%) subjects having 0.1 to 0.6, 9 (13.8%) subjects having 1 to 2, 6 (9.2%) subjects each having 0.6 to 1 and <0.1.

Conclusions: Serum C-peptide levels are useful as an index of endogenous insulin production. Low C-peptide levels need insulin treatment due to poor insulin reserve. Majority of the subjects, who had low serum C-peptide levels also had low BMI suggesting a positive correlation between C-peptide levels and BMI.


Prabhu S, Teli B. A comparative study of anaemia with the degree of glycaemic control in type 2 diabetes mellitus. Int J Adv Med. 2019;6(4):1231-5.

Global status report on noncommunicable diseases 2010. [online] Available at: <https://www.who.int/nmh/publications/ncd_report2010/en/>.

Usmani R, Gupta BK, Kaur J. Serum C-peptide and insulin levels in patients of metabolic syndrome. Int J Clinic Biochem Res. 2016;3(4):482-6.

International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.

Bamashmos M. Relationship between c-peptide and chronic complications in yemini type 2 diabetic patients. J Bio Innov. 2018;7(6):922-32.

Vlad A, Serban V, Alexandra S, Timar R, Mihaela R. The value of basal C-peptide and its relationship with pancreatic auto antibodies in young adults with type 2 diabetes mellitus. Roman J Intern Med. 2004;42(2):333-41.

Ko GTC, So W, Tong PC, Chan W, Yang X, Ma RC. Effect of interactions between C-peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus. Can Med Assoc J. 2009;180(9):907-8.

Munshi MN, Hayes M, Sternthal A, Ayres D. Use of serum C-peptide level to simplify diabetes treatment regimens in older adults. Am J Med. 2009;122(4):395-7.

Siraj ES, Reddy SS, Scherbaum WA, Abdulkadir J, Hammel JP, Faiman C. Basal and postglucagon C-peptide levels in Ethiopians with diabetes. Diabetes Care. 2002;25:453-7.

Haban P, Simoncic R, Zidekova E, Ozdin L. Role of fasting serum C-peptide as a predictor of cardiovascular risk associated with the metabolic X-syndrome. Med Sci Monit 2002;8(3):175-9.

Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, et al. A clinically oriented approach increases the effi ciency of screening for LADA in a large clinic based cohort of patients with diabetes onset over 50 years. Diabet Med. 2004;21:456-9.

Liang XJ, Zhu C, Yan C, Ni GC, Liu ZL, Du ZM, et al. Clinical significance of pancreatic beta-cell function in obese children with acanthosis nigricans. Zhonghua Er Ke Za Zhi. 2004;42:405-7.

Pfützner A, Löbig M, Fortunato A, Forst T. Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid). Clin Lab. 2003;49(5-6):227-32.

Abdullah BB, Significance of C-peptide in type 2 diabetics-a study in the north Karnataka population of India. Al Ameen J Med Sci. 2010;3(1):65-78.

Goutham VVN. Study Of serum C-peptide levels in 50 newly detected diabetes subjects of age group 30-40 years in Nellore. Int J Scientific Tech Res. 2013;2(10):196-200.






Original Research Articles